Dolutegravir Sodium Salt

Größe

£409.00

SKU:: 447645
Molekulargewicht:: 441.36
Reinheit:: ≥98%
Lagerbedingungen:: -20°C
Hersteller:: United States Biological
CAS Number:: 1051375-19-9
Format:: White to green solid
Weitere Details:: Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. Synonyms: Dolutegravir sodium; GSK 1349572A; N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide Sodium Salt CAS No: 1051375-19-9 Free Amine: 1051375-16-6 Molecular Formula: C₂₀H₁₈F₂N₃NaO₅ Molecular Weight: 441.36 Appearance: White to green solid Purity: ≥98% NMR: Conforms to structure Elemental Analysis: %C: 53.80, %H: 3.86, %N: 9.33 MS: Conforms to structure TLC Conditions: C18; Methanol : Water = 9 : 1; Visualized with UV and AMCS; Rf = 0.60 Specific Rotation: 30.6° (c = 0.1, DMSO Melting Point: >300ºC Solubility: DMSO (Slightly, Heated), Methanol (Slightly, Heated) Storage and Stability: Store at -20°C. Hygroscopic. Under inert atmosphere. For maximum recovery of product, centrifuge the original vial prior to removing the cap.